Management Series

Management of ER+ Postmenopausal Early Breast Cancer

Virtual Presentations

• The Role of Predictive Factors in Guiding Treatment Decisions for ER-Positive Postmenopausal Breast Cancer
• The Role of Predictive Factors in Guiding Treatment Decisions for ER-Positive Postmenopausal Breast Cancer
• Current Hormonal Therapy Strategies for ER-Positive Postmenopausal Breast Cancer
• Current Hormonal Therapy Strategies for ER-Positive Postmenopausal Breast Cancer
• Evaluating Long-Term Safety of Aromatase Inhibitors
• Evaluating Long-Term Safety of Aromatase Inhibitors
• Patient Case: Treatment Options for an ER-Positive Postmenopausal Woman With Early Breast Cancer

CME Modules

• The Role of Predictive Factors in Guiding Treatment Decisions for Estrogen Receptor–Positive Postmenopausal Breast Cancer
• Current Hormonal Therapy Strategies for Estrogen Receptor–Positive Postmenopausal Breast Cancer
• Evaluating Long-Term Safety of Aromatase Inhibitors

Adjuvant HER2-Positive Cancer: Integrating Prognostic Tools and Clinical Advances to Optimize Treatment

Modules

• Current Clinical Data on Adjuvant Therapy for HER2-Positive Breast Cancer
• Estimating Benefit and Prognosis With Adjuvant Therapy for HER2-Positive Breast Cancer

Interactive Case

• Treatment of a 32-Year-Old Patient With HER2-Positive Breast Cancer
• Treatment of Breast Cancer in a 64-Year-Old Black Female With Multiple Positive Lymph Nodes

CCO Slideset

• Assessing Breast Cancer Prognosis and Applications for Clinical Practice

Research Priorities in Colorectal Cancer: Recommendations of the Scientific Leadership Council in GI Cancer of the Coalition of Cancer Cooperative Groups

Modules

• Colorectal Cancer: Demographics and Screening
• Colorectal Cancer Prevention
• Colorectal Cancer Detection and Diagnosis
• Adjuvant Treatment for Rectal Cancer
• Adjuvant Treatment for Colon Cancer
• Advanced Colorectal Cancer and Novel Therapies

Research Priorities in Non-Small-Cell Lung Cancer

Modules

• Barriers to Clinical Trial Accrual and Recommendations for Improvement
• Adjuvant and Neoadjuvant Therapy for Early-Stage NSCLC
• Screening and Imaging in NSCLC
• First-Line and Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer
• Novel Therapeutic Approaches